Holen Sie sich die Stockscreener-App
28.46
2.12%
0.59
Schlusskurs vom Vortag:
$27.87
Offen:
$27.51
24-Stunden-Volumen:
789.15K
Relative Volume:
0.51
Marktkapitalisierung:
$1.82B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-218.28M
KGV:
-7.9491
EPS:
-3.5803
Netto-Cashflow:
$-186.55M
1W Leistung:
+0.39%
1M Leistung:
-6.17%
6M Leistung:
+39.58%
1J Leistung:
-39.49%
1-Tages-Spanne:
$27.19
$28.87
1-Wochen-Bereich:
$27.19
$29.90
52-Wochen-Spanne:
$18.53
$51.27
Vera Therapeutics Inc Stock (VERA) Company Profile
Firmenname
Vera Therapeutics Inc
Sektor
Branche
Telefon
650-770-0077
Adresse
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Vergleichen Sie VERA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
28.46 | 1.78B | 0 | -218.28M | -186.55M | -3.5803 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-16 | Eingeleitet | BofA Securities | Buy |
| 2025-08-04 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2025-01-28 | Eingeleitet | Goldman | Buy |
| 2024-11-21 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-01-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-12-18 | Eingeleitet | Raymond James | Outperform |
| 2023-11-10 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-16 | Eingeleitet | Guggenheim | Buy |
| 2023-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-01-04 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-07-12 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-19 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten
BK Virus Infection Market Trends, Strategies and Business Prospects 2025-2035 - GlobeNewswire Inc.
Will Vera Therapeutics Inc. stock benefit from automation2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - newser.com
How high can Vera Therapeutics Inc. stock goJuly 2025 Intraday Action & Daily Chart Pattern Signals - newser.com
Behavioral Patterns of VERA and Institutional Flows - news.stocktradersdaily.com
Ranking Vera Therapeutics Inc. among high performing stocks via toolsMarket Volume Summary & Expert Curated Trade Setups - newser.com
Can Vera Therapeutics Inc. stock sustain market leadershipMarket Movement Recap & Daily Oversold Stock Bounce Ideas - newser.com
Will Vera Therapeutics Inc. stock deliver consistent dividends2025 Macro Impact & Fast Entry Momentum Alerts - newser.com
Is Vera Therapeutics Inc. stock a defensive play in 20252025 Volatility Report & AI Powered Market Trend Analysis - newser.com
Vera Therapeutics (VERA): Is the Current Valuation Justified After Recent Volatility? - Yahoo Finance
Vera Therapeutics Inc Stock Analysis and ForecastEconomic Impact on Stocks & Budget Friendly Trading Alerts - earlytimes.in
How sustainable is Vera Therapeutics Inc. stock dividend payoutMarket Trend Summary & Reliable Volume Spike Trade Alerts - newser.com
Will Vera Therapeutics Inc. stock outperform Nasdaq index2025 Technical Overview & Daily Stock Trend Watchlist - newser.com
Redefining the Future of Autoimmune Kidney Disease: The Central Role of BAFF and APRIL - Fierce Pharma
H.C. Wainwright Maintains Its Bullish Stance on Vera Therapeutics (VERA), Sees Strong Future Revenue Growth - MSN
What MACD signals say about Vera Therapeutics Inc.July 2025 Outlook & Weekly Setup with High ROI Potential - newser.com
Vera Therapeutics Inc. stock chart pattern explainedJuly 2025 WrapUp & Risk Adjusted Swing Trade Ideas - newser.com
Historical volatility pattern of Vera Therapeutics Inc. visualized2025 AllTime Highs & Free Reliable Trade Execution Plans - newser.com
Can Vera Therapeutics Inc. stock maintain operating marginsWeekly Gains Report & Entry Point Strategy Guides - newser.com
Senior VP of Finance & Chief Accounting Officer Joseph Young Sold A Bunch Of Shares In Vera Therapeutics - 富途牛牛
How to interpret RSI for Vera Therapeutics Inc. stockWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Applying sector rotation models to Vera Therapeutics Inc.Quarterly Profit Review & Long-Term Growth Stock Strategies - newser.com
10 Best Small-Cap Biotech Stocks to Buy According to Analysts - Insider Monkey
Yale University's Strategic Investment in Vera Therapeutics Inc: A 32.26% Portfolio Stake - GuruFocus
Building trade automation scripts for Vera Therapeutics Inc.Volume Spike & Verified Chart Pattern Signals - newser.com
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):